調製(Compounding)是藥局執行業務的基本組成，今天已成為一個快速增長的領域，各種實務中的許多藥師作業正在涉及調製無菌和非無菌製劑。新開發的劑型和治療方法建議藥物和相關藥物的專門針對個別患者的產品調配，未來的幾年中將變得越來越普遍。本研究的目的是以索引的出版物從1948-2020年收錄在Scopus計有1,014篇，以文獻計量方法及可視化分析調劑藥局研究的現狀和趨勢，這將為未來的研究提供新的思路趨勢並幫助研究人員預測研究。本研究網路分析是包括對共現與作者關鍵字聚類分析與連接關連度強度、作者與被共引聚類分析與總鏈強度、來源與共引聚類分析與引文強度、書目耦合與來源聚類分析與引文強度。結果顯示出美國是居領導整個compounding pharmacy研究發展的國家，發表期刊機構及文獻數量以International Journal of Pharmaceutical Compounding機構居首位。關鍵詞以clonidine, dissolution, drug compounding, drug therapy, guidelines, medication error, pediatrics, regulation, toxicity總鏈強度最高。被引用強度以American journal of health-system pharmacy最高等。結論指出作者以Allen, Loyd Vernon(University of Oklahoma, United States)發表文獻最多，以主題Extemporaneous drug formulations,被引用最多，主要是探討當需要對嬰兒和兒童以及選定的其他人群給藥時，獲得特殊劑型的藥物至關重要。這些藥物可以臨時製備，以供個別患者使用。並評估使用機器人(APOTECAchemo)是否可以安全地實現，將細胞抑製藥物與機器人進行自動複合符合GMP的要求。全球政府針對COVID-19疫情正在放寬藥品立法，並擴大社區藥局服務，其目標是改善獲得必要醫療保健服務和藥品的機會，社區藥局的調製研究與發展將亦顯得其重要與迫切性。

“Compounding” is the basic component of a pharmaceutical operation, and it has become a rapidly growing field today. Many pharmacists in various practices are involved in the preparation of sterile and non-sterile preparations. It will become more and more common in the next few years for newly developed dosage forms and treatment methods to be specifically tailored to the need of individual patients. The purpose of this research is to process a total of 1,014 indexed publications in Scopus dated from 1948 to 2020 with bibliometrics analysis and visual analysis to form an inference regarding the future status and trends of pharmacy research, which is expected to provide new ideas and trends for future research. The network analysis of this research includes the cluster analysis of co-occurrence and author's keywords, connection relatedness strength, cluster analysis and total chain strength of author and co-citation, cluster analysis and citation strength of source and co-citation, cluster analysis and citation strength of bibliographic coupling and source cluster. The results show that the United States is the leading country in the research and development of compounding pharmacy, with the International Journal of Pharmaceutical Compounding organization ranking first in the number of journal publications and literature. The keywords are clonidine, dissolution, drug compounding, drug therapy, guidelines, medication error, pediatrics, regulation, toxicity. that total chain strength is the highest. American Journal of Health-System Pharmacy ranked the highest in cited strength. The results also point out that the author, Allen, Loyd Vernon (University of Oklahoma, United States) has published the most literature work. The most frequent cited topic is the “Extemporaneous drug formulations”, which mainly reflects exploration on the necessity to obtain tailored dosage forms when administering drugs to infants, children, and specifically selected populations. These drugs can be prepared extemporaneously for use by individual patients. Related literatures are also included to evaluate whether the use of robots (APOTECAchemo) can be safely achieved, and whether the implementation of automatic compounding process of cytostatic drugs with robots meets the GMP requirements. In response to the COVID-19 epidemic, governments around the world are relaxing drug legislation and expanding community pharmacy services. As the goal is to improve access to necessary health care services and drugs, the compounding research and development in community pharmacies will play an important and urgent role.

Alcorn T. Meningitis outbreak reveals gaps in US drug regulation.(2012) Lancet.; 380(9853):1543–4.
Alfonzo, P. M., Sakraida, T. J., & Hastings-Tolsma, M. (2014). Bibliometrics: Visualizing the impact of nursing research. Online Journal of Nursing Informatics, 18(1), 3093. Retrieved from http://ojni.org/issues/?p = 3093
Al‐Jabi, S. W. (2017). Global trends in aspirin resistance‐related research from 1990 to 2015: A bibliometric analysis. Basic & Clinical Pharmacology & Toxicology, 121(6), 512-519.
Allen, L. V. (2002). The art, science, and technology of pharmaceutical compounding (Vol. 2). Washington, DC: American Pharmaceutical Association.
Alomi, Y. A. (2020). Clinical Compounding Service: New Initiative in the Kingdom of Saudi Arabia. PTB Reports, 6(3).
Alonso-Herreros, J. M., Berisa-Prado, S., Cañete-Ramírez, C., Dávila-Pousa, C., Flox-Benítez, M. D. P., López-Cabezas, C., & Ramos-Martínez, B. (2020). Hospital Pharmacy Compounding against COVID-19 pandemic. Farmacia hospitalaria: organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria, 44(7), 49-52.
Archambault, É., Vignola-Gagné, É., Côté, G., Larivière, V., & Gingras, Y. (2006). Benchmarking scientific output in the social sciences and humanities: The limits of existing databases. Scientometrics, 68(3), 329–342.
Azarnoff, D. L., Lee, J. C., Lee, C., Chandler, J., & Karlin, D. (2007). Quality of extemporaneously compounded nitroglycerin ointment. Diseases of the colon & rectum, 50(4), 509-516.
Balado, A. C., Garcia-Quintanilla, L., Mondelo-García, C., González-Barcia, M., Zarra-Ferro, I., & Fernández-Ferreiro, A. (2020). 3PC-031 Current state of the anti-infective ophthalmic compounding formulation in pharmacy services: a national survey.
Barnes, A. C., Rathbun, S. L., Kuthyar, S., Hubbard, G. B., Bergstrom, C., Yeh, S., & Iyer, M. N. (2021). Clinical management of an outbreak of nutritionally variant streptococcus endophthalmitis following intravitreal bevacizumab injection. International Journal of Retina and Vitreous, 7(1), 1-7.
Barrera K, McNicoll C, Sangji N. Drug shortages: the invisible epidemic. Bulletin of the American College of Surgeons November 1, 2018. https://bulletin.facs.org/2018/11/drugshortages-the-invisible-epidemic/. Accessed June 29, 2020.
Bertoli-Barsotti, L., & Lando, T. (2017). A theoretical model of the relationship between the h-index and other simple citation indicators. Scientometrics, 111(3), 1415-1448.
Bhakta, S. B., Carmine Colavecchia, A., Coffey, W., Curlee, D. R., & Garey, K. W. (2018). Implementation and evaluation of a sterile compounding robot in a satellite oncology pharmacy. The Bulletin of the American Society of Hospital Pharmacists, 75(11_Supplement_2), S51-S57.
Borgman, C. L., & Furner, J. (2002). Scholarly communication and bibliometrics. Annual review of information science and technology, 36(1), 2-72.
Burch, J. (2017). Compounding pharmacists provide customized care. North Carolina Medical Journal, 78(3), 191-194.
Buurma, H., De Smet, P. A., van den Hoff, O. P., Sysling, H., Storimans, M., & Egberts, A. C. (2003). Frequency, nature and determinants of pharmacy compounded medicines in Dutch community pharmacies. Pharmacy World and Science, 25(6), 280-287.
Cawthon, M. (2016). Patient experiences with small-scale pharmacy compounding.
Centers for Disease Control and Prevention (CDC. (2002). Exophiala infection from contaminated injectable steroids prepared by a compounding pharmacy--United States, July-November 2002. MMWR. Morbidity and mortality weekly report, 51(49), 1109-1112.
Chollet, J. L., & Jozwiakowski, M. J. (2012). Quality investigation of hydroxyprogesterone caproate active pharmaceutical ingredient and injection. Drug development and industrial pharmacy, 38(5), 540-549.
Chung, J., & Tsay, M. Y. (2017). A bibliometric analysis of the literature on open access in scopus. Qualitative and Quantitative Methods in Libraries, 4(4), 821-841.
Cimolai N. Penicillin VK oral suspension. Can Med Assoc J. 2015;187(6):439.2–439.
Compounding activities: COVID-19. U.S. Food & Drug Administration. April 7, 2020. https://www.fda.gov/drugs/coronavirus-covid-19-drugs/compounding-activities-covid-19.Accessed June 29, 2020.
Compounding and the FDA: Questions and Answers. Available online: https://www.fda.gov/drugs/guidancecomplianceregulatoryinformation/pharmacycompounding/ucm339764.htm (accessed on 23 April 2019)
DeLegge MH. Parenteral nutrition therapy over the next 5–10 years: where are we heading? J Parenter Enter Nutr. 2012;36(Supplement 2):56S–61S.
Diem, A., & Wolter, S. C. (2013). The use of bibliometrics to measure research performance in education sciences. Research in higher education, 54(1), 86-114.
Geersing, T. H., Klous, M. G., Franssen, E. J. F., van den Heuvel, J. J. G., & Crul, M. (2020). Robotic compounding versus manual compounding of chemotherapy: Comparing dosing accuracy and precision. European Journal of Pharmaceutical Sciences, 155, 105536.
Gilbert RE, Kozak MC, Dobish RB, Bourrier VC, Koke PM, Kukreti V, et al. Intravenous chemotherapy compounding errors in a follow-up pan-Canadian observational study. J Oncol Pract. 2018;14(5):e295–303.
Gingras, Y. (2014). Les dérives de l’évaluation de la recherche : du bon usage de la bibliométrie. Paris:Raisons d’agir
Glass, G. V. (1976). Primary, secondary, and meta-analysis of research. Educational researcher, 5(10), 3-8.
Goldman, M. P. (2004). Sodium tetradecyl sulfate for sclerotherapy treatment of veins: is compounding pharmacy solution safe?. Dermatologic surgery, 30(12p1), 1454-1456.
Goode, C. J., McCarty, L., Fink, R., Oman, K., Makic, M., Krugman, M., & Traditi, L. (2013). Mapping the organization: A bibliometric analysis of nurses’ contributions to the literature. Journal of Nursing Administration, 43(9), 481–487. https://doi.org/10.1097/NNA.0b013e3182a23db5
Goyanes, A., Martinez, P. R., Buanz, A., Basit, A. W., & Gaisford, S. (2015). Effect of geometry on drug release from 3D printed tablets. International journal of pharmaceutics, 494(2), 657-663.
Goyanes, A., Allahham, N., Trenfield, S. J., Stoyanov, E., Gaisford, S., & Basit, A. W. (2019). Direct powder extrusion 3D printing: Fabrication of drug products using a novel single-step process. International journal of pharmaceutics, 567, 118471.
Green, D. M., Jones, A. C., & Brain, K. R. (2012). Content variability of active drug substance in compounded oral 3, 4‐diaminopyridine products. Journal of clinical pharmacy and therapeutics, 37(1), 53-57.
Geersing, T. H., Franssen, E. J. F., Pilesi, F., & Crul, M. (2019). Microbiological performance of a robotic system for aseptic compounding of cytostatic drugs. European Journal of Pharmaceutical Sciences, 130, 181-185.
Gudeman J, Jozwiakowski M, Chollet J, Randell M. Potential risks of pharmacy compounding. Drugs RD. 2013;13(1):1–8.
Gu, D., Li, J., Li, X., & Liang, C. (2017). Visualizing the knowledge structure and
evolution of big data research in healthcare informatics. International journal of
medical informatics, 98, 22-32.
Guharoy R, Noviasky J, Haydar Z, Fakih MG, Hartman C. Compounding pharmacy conundrum. Chest. 2013;143(4):896–900.
Heitman, T., Day, A. J., & Bassani, A. S. (2019). Pediatric Compounding Pharmacy: Taking on the Responsibility of Providing Quality Customized Prescriptions. Children, 6(5), 66.
Hsu Chin-hsing (2020). Network and Topic Analysis of the Artificial Intelligence Research in Medicine. Department of Business Administration, National Central University, Taiwan, PhD thesis.
Iwamoto, T., Morikawa, T., Hioki, M., Sudo, H., Paolucci, D., & Okuda, M. (2017). Performance evaluation of the compounding robot, APOTECAchemo, for injectable anticancer drugs in a Japanese hospital. Journal of pharmaceutical health care and sciences, 3(1), 1-8.
Jobard, M., Brandely-Piat, M. L., Chast, F., & Batista, R. (2020). Qualification of a chemotherapy-compounding robot. Journal of Oncology Pharmacy Practice, 26(2), 312-324.
Kainer MA, Reagan DR, Nguyen DB, Wiese AD, Wise ME, Ward J, et al. Fungal infections associated with contaminated methylprednisolone in Tennessee. N Engl J Med. 2012;367(23):2194–203.
Kastango, E. S. (2004). Quality-control analytical methods: USP chapter< 797> compounded sterile preparations sterility requirements and their relationship to beyond-use dating. International Journal of Pharmaceutical Compounding, 8(5), 393.
Kirby, A. V., Dickie, V. A., & Baranek, G. T. (2015). Sensory experiences of children with autism spectrum disorder: In their own words. Autism, 19(3), 316-326.
Kosari, S., Buss, V. H., Peterson, G. M., Yee, K. C., Naunton, M., Bushell, M., ... & Thomas, J. (2020). Evaluation of pharmaceutical compounding training in the Australian undergraduate pharmacy curricula. Pharmacy, 8(1), 27.
Lateef, F. (2010). Simulation-based learning: Just like the real thing. Journal of Emergencies, Trauma and Shock, 3(4), 348.
Lewis, B. R., Templeton, G. F., & Luo, X. (2007). A scientrometric investigation into the validity of IS journal quality measures. Journal of the Association for Information Systems, 8(12), 619–633.
Liang, C., Luo, A., & Zhong, Z. (2018). Knowledge mapping of medication literacy study: a visualized analysis using CiteSpace.
Liao, H., Tang, M., Luo, L., Li, C., Chiclana, F., & Zeng, X. J. (2018). A bibliometric analysis and visualization of medical big data research. Sustainability, 10(1), 166.
Limayem, M., Hirt, S.G., & Christy M.K. Cheung. (2003). Habit in the context of IS
continuance: Theory extensionand scale development. Proceedings of the 11th Euro⁃pean Conference on Information Systems.
Lin, H.-M. (2017). Bibliometrics and Visualization Analysis of Long-term Care.
Liu, X., Zhan, F. B., Hong, S., Niu, B., & Liu, Y. J. S. (2012). A bibliometric study of
earthquake research: 1900–2010. 92(3), 747-765.
Mahaguna, V., McDermott, J. M., Zhang, F., & Ochoa, F. (2004). Investigation of product quality between extemporaneously compounded progesterone vaginal suppositories and an approved progesterone vaginal gel. Drug development and industrial pharmacy, 30(10), 1069-1078.
Marco, E. J., Hinkley, L. B., Hill, S. S., & Nagarajan, S. S. (2011). Sensory processing in autism: a review of neurophysiologic findings. Pediatric research, 69(8), 48-54.
McPherson, T. B., Fontane, P. E., Jackson, K. D., Berry, T., Chereson, R., Bilger, R., & Martin, K. S. (2006). Prevalence of compounding in independent community pharmacy practice. Journal of the American Pharmacists Association, 46(5), 568-573.
Merigó, J. M., Cancino, C. A., Coronado, F., & Urbano, D. (2016). Academic research in innovation: a country analysis. Scientometrics, 108(2), 559-593.
Merks, P., Jakubowska, M., Drelich, E., Świeczkowski, D., Bogusz, J., Bilmin, K., ... & Vaillancourt, R. (2020). The legal extension of the role of pharmacists in light of the COVID-19 global pandemic–A review. Research in Social and Administrative Pharmacy.
Minghetti, P., Pantano, D., Gennari, C. G. M., & Casiraghi, A. (2014). Regulatory framework of pharmaceutical compounding and actual developments of legislation in Europe. Health Policy, 117(3), 328-333.
Misiewicz Runyon A, So T-Y. The use of ketogenic diet in pediatric patients with epilepsy. ISRN Pediatr. 2012;2012:1–10.
Missouri Board of Pharmacy Compounding Report. FY2006–2009. http://pr.mo.gov/pharmacists-compounding.asp. Accessed Jan 2021.
Mohiuddin, A. K. (2019). Extemporaneous Compounding: Cautions, Controversies and Convenience. International Journal of Health and Clinical Research, 2(1), 1-16.
Mohiuddin, A. K. (2020). Extemporaneous compounding: Selective pharmacists with separate skill. International Journal of Pharmaceutical Chemistry and Analysis, 5(4), 165-178.
Monestime, S., Thomas, D., Hooper, C. D., Day, T., Suzuki, S., & Martin, R. D. (2020). Instructional and Assessment Redesign of a Sterile Compounding Course Using Immersive Simulation. American journal of pharmaceutical education, 84(2).
Mongeon, P., & Paul-Hus, A. (2016). The journal coverage of Web of Science and Scopus: a comparative analysis. Scientometrics, 106(1), 213-228.
Morris AM, Schneider PJ, Pedersen CA, et al.National survey of quality assurance activities for pharmacy-compounded sterile preparations. Am J Health Syst Pharm 2003; 60:2567–76.
Myers CE. Needed: serious attention to sterile products. Am J Health Syst Pharm 1996; 53:2582.
Nadeem, M. F., Samanta, S., & Mustafa, F. (2021). Is the paradigm of community
pharmacy practice expected to shift due to COVID-19?. Research in Social &
Administrative Pharmacy, 17(1), 2046.
National Community Pharmacy Association. Community Pharmacy Compounding Survey. Alexandria, VA: National Community Pharmacist Association; 2012. http://www.ncpanet.org/pdf/Survey-compounding-results.pdf.
Nees Jan van Eck and Ludo Waltman (2018). Manual for VOSviewer version 1 .6.8.
Nerur, S. P., Rasheed, A. A., & Natarajan, V. (2008). The intellectual structure of the
strategic management field: An author co‐citation analysis. Strategic Management Journal, 29(3), 319-336.
Nigro, F., Tavares, M., & de Bustamante, M. S. D. S. (2020) Community actions of a University Compounding Pharmacy against COVID-19. Research in Social & Administrative Pharmacy.
Niu, J., Tang, W., Xu, F., Zhou, X., & Song, Y. (2016). Global Research on Artificial Intelligence from 1990–2014: Spatially-Explicit Bibliometric Analysis. ISPRS International Journal of Geo-Information, 5(5), 66.
Nurgat, Z., Faris, D., Mominah, M., Vibar, A., Al-Jazairi, A., Ewing, S., ... & Al-Jedai, A. (2015). A three-year study of a first-generation chemotherapy-compounding robot. American Journal of Health-System Pharmacy, 72(12), 1036-1045.。
Oermann,M. H., Nordstrom, C. K.,Wilmes, N. A., Denison, D., Webb, S. A., Featherston, D. E., . . . Striz, P. (2008).Information sources for developing the nursing literature.International Journal of Nursing Studies, 45(4), 580–587.
https://doi.org/10.1016/j.ijnurstu.2006.10.005
Osareh, F. (1996). Bibliometrics, citation analysis and co-citation analysis: A review of literature I. Libri, 46(3), 149-158.
Outterson K. Regulating compounding pharmacies after NECC. N Engl J Med. 2012;367(21):1969–72.
Palma, E., & Bufarini, C. (2012). Robot-assisted preparation of oncology drugs: The role of nurses. International Journal of Pharmaceutics, 439(1-2), 286-288.
Pappas, A., MacPherson, R., & Stewart, K. (2002). Extemporaneous prescribing: whatever happened to it? A survey of Australian general practitioners. Journal of Pharmacy Practice and Research, 32(4), 310-314.
Pegues, D. A. (2006). Improving and enforcing compounding pharmacy practices to protect patients.
Peng, L., & Ni, X. (2021). Intravenous compounding robots in pharmacy intravenous admixture services: a health technology assessment.
Penzien, C. E., Tharp, J. C., Mulzer, K., Rurka, C., Abbas, C., & Chaffee, B. W. (2020). Development of a sterile compounding training and competency program at a large academic medical center. American Journal of Health-System Pharmacy, 77(24), 2089-2100.
Pettit, A. C., Kropski, J. A., Castilho, J. L., Schmitz, J. E., Rauch, C. A., Mobley, B. C., ... & Pugh, M. E. (2012). The index case for the fungal meningitis outbreak in the United States. New England Journal of Medicine, 367(22), 2119-2125.
Pinto, M., Pulgarín, A., & Escalona, M. I. (2014). Viewing information literacy
concepts: a comparison of two branches of knowledge. Scientometrics, 98(3),
2311-2329.
Pritchard, A. (1969). Statistical bibliography or bibliometrics. Journal of documentation, 25(4), 348-349.
Preparations, P. C. S. (2012). USP-NF General Chapter< 797>. In United States Pharmocopeia, 35th revision and the National Formulary. 30th ed. Rockville, MD: The United States Pharmacopoeia Convention.
Rhoads, R., Exner, L., & Wagner, J. T. (2020). Demystifying dynamic smoke pattern tests for sterile compounding pharmacies. American Journal of Health-System Pharmacy, 77(1), 56-60.
Robles-Martinez, P., Xu, X., Trenfield, S. J., Awad, A., Goyanes, A., Telford, R., ... & Gaisford, S. (2019). 3D printing of a multi-layered polypill containing six drugs using a novel stereolithographic method. Pharmaceutics, 11(6), 274.
Santell JP, Kamalich RF. National survey of quality assurance activities for pharmacy-prepared sterile products in hospitals and home infusion facilities, 1995. Am J Health Syst Pharm 1996; 53:2591–605.
Sasich LD, Sukkari SR. Unknown risks of pharmacy-compounded drugs. J Am Osteopath Assoc. 2008;108(2):86.
Scheepers, H. P. A., Handlos, V. N., Walser, S., Schutjens, M. D. B., & Neef, C. (2017). Impact of the Council of Europe Resolution on quality and safety assurance requirements for medicinal products prepared in pharmacies for the special needs of patients. European Journal of Hospital Pharmacy, 24(4), 218-223.
Sicherer, S. H., & Sampson, H. A. (2014). Food allergy: epidemiology, pathogenesis, diagnosis, and treatment. Journal of Allergy and Clinical Immunology, 133(2), 291-307.
Schneider, P. J., Pedersen, C. A., & Scheckelhoff, D. J. (2018). ASHP national survey of pharmacy practice in hospital settings: dispensing and administration—2017. The Bulletin of the American Society of Hospital Pharmacists, 75(16), 1203-1226.
Sklenar Z, Scigel V, Horackova K, Slanar O. Compounded preparations with nystatin for oral and oromucosal administration. Acta Poloniae Pharmaceutica - Drug Research. 2013;70(4):759–62.
Smith, E. K. (2020). Surface disinfection practice in a hospital pharmacy aseptic compounding unit. Journal of Pharmacy Practice and Research, 50(2), 132-136.
Smith RM, Schaefer MK, KainerMA,Wise M, Finks J, Duwve J, et al. Fungal infections associated with contaminated methylprednisolone injections. N Engl J Med. 2013;369(17):1598–609.
Sterility Tests (general chapter 71). United States Pharmacopeia 35—National Formulary 30. Rockville: United States Pharmacopeial Convention; 2012.
Sweileh, W. M., Al-Jabi, S. W., AbuTaha, A. S., Sa’ed, H. Z., Anayah, F. M., & Sawalha, A. F. (2017). Bibliometric analysis of worldwide scientific literature in mobile-health: 2006–2016. BMC medical informatics and decision making, 17(1), 1-12.
Temporary policy for compounding of certain drugs for hospitalized patients by pharmacy compounders not registered as outsourcing facilities during the COVID-19 public health emergency (revised): guidance for industry. United States Food and
Drug Administration. May 21, 2020. https://www.fda.gov/media/137125/download. Accessed June 29, 2020.
Texas State Board of Pharmacy, Business Meeting Minutes, November 9, 2010, Report on TSBP Sampling of Compounded Products, Tab 24. 2010. http://www.tsbp.state.tx.us/files_pdf/BN/Nov10/Additions/Tab24_Compounded%20Sample%20Testing.pdf. Accessed Jan 2021.
Todorova, A., Gugleva, V., & Georgieva, L. (2016). Doctors’ point of view on Pharmacy Compounding-Advantages and disadvantages. IAIM, 3 (2), 45-50.
Trenfield, S. J., Awad, A., Goyanes, A., Gaisford, S., & Basit, A. W. (2018). 3D printing pharmaceuticals: drug development to frontline care. Trends in pharmacological sciences, 39(5), 440-451.
United States Food and Drug Administration. Limited FDA Survey of Compounded Drug Products. 2001. http://www.fda.gov/Drugs/GuidanceComplianceRegulatoryInformation/PharmacyCompounding/ucm155725.htm. Accessed Jan 2021.
US Food and Drug Administration. Pharmacy Compounding. 2006 Limited FDA Survey of Compounded Drug Products. 2012. http://www.fda.gov/Drugs/GuidanceComplianceRegulatoryInformation/PharmacyCompounding/ucm204237.htm. Accessed Jan 2021.
United States Food and Drug Administration. Updated FDA Statement on Compounded Versions of hydroxyprogesterone caproate (the active ingredient in Makena). 2012. http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm308546.htm. Accessed Jan 2021.
United States Food and Drug Adminstration. Questions and Answers on Updated FDA Statement on Compounded Versions of hydroxyprogesterone caproate (the active ingredient in Makena). 2012. http://www.fda.gov/newsevents/newsroom/pressannouncements/ucm310215.htm. Accessed Jan 2021.
Van Eck, N. J., & Waltman, L. (2010). Software survey: VOSviewer, a computer program for bibliometric mapping. scientometrics, 84(2), 523-538.
Watson, C. J., Whitledge, J. D., Siani, A. M., & Burns, M. M. (2020). Pharmaceutical Compounding: a History, Regulatory Overview, and Systematic Review of Compounding Errors. Journal of Medical Toxicology, 1-21.
Werumeus Buning, A., Geersing, T.H., Crul, M., 2020. The assessment of environmental and external cross-contamination in preparing ready-to-administer cytotoxic drugs: a comparison between a robotic system and conventional manual production. Int. J. Pharm. Pract. 28 (1), 66–74. https://doi.org/10.1111/ijpp.12575.
Williams NT. Medication administration through enteral feeding tubes. Am J Health Syst Pharm. 2008;65(24):2347–57.
Wouters, P. (2006). Aux origines de la scientométrie: La naissance du Science Citation Index. Actes de La Recherche En Sciences Sociales, 4(164), 10–21. http://doi.org/10.3917/arss.164.0011
Xing, D., Zhao, Y., Dong, S., & Lin, J. (2018). Global research trends in stem cells for osteoarthritis: a bibliometric and visualized study. International journal of rheumatic diseases, 21(7), 1372-1384.
Yang X, Fang P,Xiang D,Yang Y. Topical treatments for diabetic neuropathic pain (review). Exp Ther Med. 2019;17:1963–76.
Yaniv, A. W., & Knoer, S. J. (2013). Implementation of an iv-compounding robot in a hospital-based cancer center pharmacy. American journal of health-system pharmacy, 70(22), 2030-2037.
Young, D., Outsourced compounding can be problematic: community pharmacies linked to contaminated injectables. (2002): 59:2261-2264.
Younis US, Fazel M, Myrdal PB. Characterization of tetracycline hydrochloride compounded in a miracle mouthwash formulation. AAPS PharmSciTech. 2019;20(5):1–8.
Zaid, A. N., Al‐Ramahi, R., Shahed, Q., Saleh, B., & Elaraj, J. (2012). Determinants and frequency of pharmaceutical compounding in pharmacy practice in Palestine. International Journal of Pharmacy Practice, 20(1), 9-14.
Zhu, J., & Liu, W. (2020). A tale of two databases: the use of Web of Science and Scopus in academic papers. Scientometrics, 1-15.
Zhu, Y., Li, J. J., Reng, J., Wang, S., Zhang, R., & Wang, B. (2020). Global trends of Pseudomonas aeruginosa biofilm research in the past two decades: A bibliometric study. MicrobiologyOpen, e1021.
Zock, M. D., Soefje, S., & Rickabaugh, K. (2011). Evaluation of surface contamination with cyclophosphamide following simulated hazardous drug preparation activities using two closed-system products. Journal of Oncology Pharmacy Practice, 17(1), 49-54.